RhumbLine Advisers’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
Other funds holding OSIR
HP
FIM
FPF
IA
MAM
RhumbLine Advisers's OSIR Position: Q1 2017 in Review
RhumbLine Advisers sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 20,882 shares — an estimated $103K sold.
RhumbLine Advisers first reported a position in OSIR in Q2 2013 and held it in 15 quarters. The position peaked at $371K in Q2 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.
- RhumbLine Advisers reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
- RhumbLine Advisers sold 20,882 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $103K.
- RhumbLine Advisers first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 15 quarters.
- RhumbLine Advisers's Osiris Therapeutics, Inc. Common Stock position peaked at $371K in Q2 2015.
- 11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.